Once scarce, Paxlovid, an antiviral pill that is the preferred treatment for non-hospitalized high-risk COVID-19 patients, is no longer in such short supply. Here, we explain what the drug does, how well it works and what questions remain.
Background Science
When the Science Is Messy: How SciCheck Handles Scientific Disputes
Q&A on Second COVID-19 Boosters for Older People
Q&A on At-Home Rapid Tests
Early Data on Omicron
Q&A on the Omicron Variant
On Nov. 24, South Africa told the World Health Organization that amid a recent increase in COVID-19 cases, it had identified a new variant — later named omicron — with a high number of mutations, raising concerns that it could spread more easily than other variants of the coronavirus. We’ll go through what we know so far about omicron.